Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (24 quarters reported)
$169M in Q4 2017 → $8.69M now. Hover for any quarter.
As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Biora Therapeutics Inc. | 63.1% | Unchanged | 10,929,762 | $5.48M |
| Puma Biotechnology Inc | 36.9% | Unchanged | 1,256,411 | $3.2M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2024 · filed November 12, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CB Coherus Biosciences Inc | Exited | −30,000,000 | −$22.2M | — |
quarter ended June 30, 2024 · filed August 08, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Omeros Corp | Exited | −72,979,000 | −$54.1M | — |
| CB Coherus Biosciences Inc | New | +30,000,000 | +$22.2M | 66.3% |
quarter ended March 31, 2024 · filed May 16, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Puma Biotechnology Inc | Trimmed | −535,703 | −$2.84M | 9.1% |
quarter ended December 31, 2023 · filed February 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| B Biora Inc. | Exited | −53,500,000 | −$28M | — |
| Omeros Corp | Exited | −11,005,000 | −$11.3M | — |
| Rvl Pharmaceuticals PLC | Exited | −14,600,444 | −$1.26M | — |
quarter ended September 30, 2023 · filed November 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| B Biora Inc. | Trimmed | −50,000,000 | −$26.1M | 24.6% |
| B Biora Inc. | Added | +9,235,281 | +$20M | 20.9% |
| PP Paratek Pharmaceuticals Inc. | Exited | −9,000,000 | −$8.85M | — |
| Omeros Corp | Added | +1,000,000 | +$612K | 39.3% |
quarter ended June 30, 2023 · filed August 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AP Amryt Pharma PLC | Exited | −8,857,268 | −$129M | — |
| Omeros Corp | Added | +6,843,000 | +$5.02M | 34.2% |
quarter ended March 31, 2023 · filed May 16, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Caremax Inc | Exited | −4,467,219 | −$16.3M | — |
| Omeros Corp | Trimmed | −10,000,000 | −$10.1M | 4.0% |
| Bridgebio Pharma Inc. | Exited | −20,000,000 | −$7.75M | — |
| B Biora Inc. | Exited | −42,362,097 | −$5.58M | — |
| Omeros Corp | Added | +7,005,000 | +$5M | 16.7% |
| B Biora Inc. | New | +1,694,481 | +$4.69M | 1.7% |
| Societal Cdmo Inc. | Exited | −2,202,420 | −$3.28M | — |
quarter ended December 31, 2022 · filed February 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Omeros Corp | Added | +17,981,000 | +$9.81M | 13.3% |
| B Biora Inc. | Added | +12,506,250 | +$1.65M | 2.3% |
Loading...
